Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

18 Jan 2017 07:00

RNS Number : 4085U
Quartix Holdings PLC
18 January 2017
 

18 January 2017

Quartix Holdings plc

("Quartix" or the "Company")

 

Trading Statement

Quartix Holdings plc, one of Europe's leading suppliers of subscription-based vehicle tracking systems, software and services, reports that it will publish results for the year ended 31st December 2016 on Monday 27th February 2017.

Revenue for the period is anticipated to be slightly ahead of market expectations and profit is expected to be in line with expectations. Free cash-flow continued at a strong level, and the Company expects to be in a position to pay a supplementary dividend along with the final dividend, in line with the policy it announced in February 2016. The results, together with accompanying presentations, will be posted on the Company's website at www.quartix.net/investors, and shareholders will be welcome to submit any questions for management via the site.

The Company's subscription base in its core fleet operations increased by 14% in the UK to over 71,000 vehicles, by 95% in the USA to more than 6,000 vehicles, and by 26% in France to just under 10,000 vehicles.

New unit installations in the insurance sector grew by 22% to 69,000 vehicles. Despite this growth, installations in the second half were 13% lower than in the first half. This trend was in keeping with the decision announced at the time of the Company's interim results in July to focus on its core fleet market and on only those insurance opportunities which offer satisfactory margins and which are closely aligned to its fleet business, a trend we see increasing in 2017. Quartix continues to take steps to manage its cost base in line with this strategy, particularly given continued price pressure in the insurance market.

Our strong financial performance in the year allowed us to increase investment in key product and market developments in the second half. We believe that the Company has significant opportunity for growth in its fleet business, particularly in the USA. We ended the year with good growth in fleet installations in the USA and have taken the decision to make additional investment in business development in 2017. The additional investment, taken together with the strategic decision to move away from low margin insurance sales means that we are now expecting to deliver 2017 results broadly in line with 2016 results.

Andy Walters, Managing Director, commented: "We are delighted with the progress made in 2016, having increased our fleet subscription base by 19% to more than 87,000 vehicles in total. We completed some key product initiatives and expanded our footprint in the USA and now believe that it is appropriate to increase investment in the development of this market, which we estimate to be more than 5 times the size of the UK market. I look forward to updating shareholders on these initiatives at the time of our results announcements."

 

 

For further information, please contact:

 

Quartix (www.quartix.net)

Andy Walters, Managing Director

David Bridge, Finance Director

01686 806 663

 

finnCap (Nominated Adviser and Broker)

Matt Goode / Scott Mathieson (Corporate Finance)

Stephen Norcross (Corporate Broking)

 

020 7200 0500

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMMRNKGNZM
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.